4D MOLECULAR THERAPEUTICS INC. - COMMON STOCK

4DMT Announces New Employment Inducement Grants

17 янв 2026 08:00:51 Источник Nasdaq GlobeNewswire

4DMT Provides Company Update and Anticipated Development Milestones for 2026

07 янв 2026 08:00:00 Источник Nasdaq GlobeNewswire

4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease

17 дек 2025 07:00:00 Источник Nasdaq GlobeNewswire

4DMT Announces New Employment Inducement Grants

12 дек 2025 16:05:00 Источник Nasdaq GlobeNewswire

4DMT to Participate in 8th Annual Evercore Healthcare Conference

20 ноя 2025 08:00:01 Источник Nasdaq GlobeNewswire

4DMT Appoints Kristian Humer as Chief Financial Officer

17 ноя 2025 06:00:00 Источник Nasdaq GlobeNewswire

4DMT Announces New Employment Inducement Grants

14 ноя 2025 16:05:00 Источник Nasdaq GlobeNewswire

4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

10 ноя 2025 08:00:01 Источник Nasdaq GlobeNewswire

4DMT to Participate in Jefferies 2025 London Healthcare Conference

06 ноя 2025 16:05:02 Источник Nasdaq GlobeNewswire

4DMT Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants

06 ноя 2025 06:23:59 Источник Nasdaq GlobeNewswire

4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting 4D-150’s Potential as a Backbone Therapy with Consistent and Durable Benefit over Multiple Years

06 ноя 2025 06:00:00 Источник Nasdaq GlobeNewswire

4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific

30 окт 2025 23:02:12 Источник Nasdaq GlobeNewswire

4DMT Announces New Employment Inducement Grants

17 окт 2025 16:05:00 Источник Nasdaq GlobeNewswire

4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference

14 окт 2025 08:00:51 Источник Nasdaq GlobeNewswire

4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation

13 окт 2025 08:00:00 Источник Nasdaq GlobeNewswire

4DMT Announces New Employment Inducement Grants

12 сен 2025 16:05:00 Источник Nasdaq GlobeNewswire

4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness

02 сен 2025 08:00:00 Источник Nasdaq GlobeNewswire

4DMT to Participate in Upcoming Investor Conferences

25 авг 2025 08:00:01 Источник Nasdaq GlobeNewswire

4DMT Announces New Employment Inducement Grants

15 авг 2025 16:05:00 Источник Nasdaq GlobeNewswire

4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

11 авг 2025 08:00:00 Источник Nasdaq GlobeNewswire